Extract Labs unveils CBG and CBD tincture blend amid mounting COVID-19 evidence

17 Jan 2022 --- CBD extraction retailer Extract Labs is unveiling an Immune Support CBGa (cannabigerolic acid) CBDa (cannabidiolic acid) tincture. The US-based company says these compounds may offer potential avenues to help prevent and treat COVID-19, as suggested in recent research.

The blend of raw hemp ingredients is extracted from Colorado-grown hemp and lab-tested for purity. The 2000 mg tincture blend consists of CBGa, CBDa, CBG and CBD compounds in a 1:1:1:1 500 mg ratio.

According to researchers from Oregon State University, the two cannabinoid acids commonly found in hemp, CBGa and CBDa, can bind to the spike protein of SARS-CoV-2, the virus that causes COVID-19. This binding thus prevents the virus from entering cells and causing an infection.

Commenting on the capabilities of the Immune Support Tincture, Craig Henderson, CEO and founder of Extract Labs, says: “We are launching the Immune Support Tincture at a critical time where research continues to show that cannabis compounds, including CBGa and CBDa, have significant effects on supporting the prevention of COVID infection.”According to Extract Labs, the CBGa and CBDa compounds can prevent the COVID-19 virus from causing infection by binding to the spike protein.

The research scientist from Oregon State University adds that: “With the widespread use of cannabinoids, resistant variants could still arise, but the combination of vaccination and CBDa/CBGa treatment should create a more challenging environment with which SARS-CoV-2 must contend, reducing the likelihood of escape.”

Combining CBGa and CBDa
Extract Labs’ Immune Support Tincture is marketed as the first consumer product to contain CBGa. Other tinctures on the market only have traces of CBGa and CBDa. While the difference may seem minor, CBD and CBG are different molecules than their acidic precursors.

Moreover, CBGa and CBDa are rarer as most extraction and refinement processes require heat to perform them efficiently. The heat will often cause CBDa and CBGa to convert to CBD and CBG, respectively – converting the cannabinoids at a molecular level.

Potential treatments and prevention for COVID-19
Previous research has found various ingredients may hold potential in the fight against COVID-19. Last week, according to a scientific investigation, a probiotic product from AB-Biotics had “significant” beneficial effects in COVID-19 outpatients, presumably by altering the gut-lung axis (GLA).

Meanwhile, ADM’s probiotic strains Bifidobacterium longum CECT7347, Bifidobacterium animalis subsp. lactis CECT9950 and Lactobacillus rhamnosus CNCM-I4036 were trialed on patients with COVID-19 in a Spanish hospital.

By Nicole Kerr

To contact our editorial team please email us at editorial@cnsmedia.com